Nanopore sequencing for the screening of myeloid and lymphoid neoplasms with eosinophilia and rearrangement of PDGFRα, PDGFRβ, FGFR1 or PCM1-JAK2

Eosinophilia represents a group of diseases with heterogeneous pathobiology and clinical phenotypes. Among the alterations found in primary Eosinophilia, gene fusions involving PDGFRα, PDGFRβ, FGFR1 or JAK2 represent the biomarkers of WHO-defined “myeloid and lymphoid neoplasms with eosinophilia”. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Romagnoli, Simone, Bartalucci, Niccolò, Gesullo, Francesca, Balliu, Manjola, Bonifacio, Stefania, Fernandez, Anair Graciela Lema, Mannelli, Francesco, Bolognini, Davide, Pelo, Elisabetta, Mecucci, Cristina, Guglielmelli, Paola, Vannucchi, Alessandro Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588648/
https://www.ncbi.nlm.nih.gov/pubmed/34772467
http://dx.doi.org/10.1186/s40364-021-00337-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8588648/
https://www.ncbi.nlm.nih.gov/pubmed/34772467
http://dx.doi.org/10.1186/s40364-021-00337-1

Ejemplares similares